Use of canagliflozin in combination with and compared to incretin-based therapies in type 2 diabetes

Richard E. Pratley, Eugenio Cersosimo

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Use of canagliflozin in combination with and compared to incretin-based therapies in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences